EMEA (Europe, Middle East and Africa) Cell-based Assays Market Report 2017

December 2017 | 127 pages | ID: ED7CA04A4DFEN
QYResearch

Abstracts

In this report, the EMEA Cell-based Assays market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Cell-based Assays for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cell-based Assays market competition by top manufacturers/players, with Cell-based Assays sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• BD Medical (US)
• Danaher (US)
• Thermo Fisher Scientific (US)
• General Healthcare (UK)
• Merck KGaA (Germany)
• Perkinelmer (US)
• Charles River Laboratories (US)
• Life Technologies (US)
• Lonza Group (Switzerland)
• Cell Signaling Technology (US)
• Promega (US)
• Cisbio Bioassays (France)
• Discoverx (US)
• Proqinase GmbH (Germany)
• Marine Biological Laboratory (US)
• Biospherix (US)
• Essen Bioscience (US)
• Miltenyi Biotec (Switzerland)
• Bioagilytix Labs (US)
• Cell Biolabs (US)
• Biotek Instruments (US)
• Qgel SA (Switzerland)
• Enzo Life Sciences (Switzerland)
• Aurelia Bioscience (UK)
• Selexis SA (US)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Consumables
• Instruments
• Services
• Software

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pharmaceutical & Biotechnology Companies
• Academic & Government Institutions
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Cell-based Assays Market Report 2017

1 CELL-BASED ASSAYS OVERVIEW

1.1 Product Overview and Scope of Cell-based Assays
1.2 Classification of Cell-based Assays
  1.2.1 EMEA Cell-based Assays Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Cell-based Assays Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Consumables
  1.2.4 Instruments
  1.2.5 Services
  1.2.6 Software
1.3 EMEA Cell-based Assays Market by Application/End Users
  1.3.1 EMEA Cell-based Assays Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Pharmaceutical & Biotechnology Companies
  1.3.3 Academic & Government Institutions
  1.3.4 Other
1.4 EMEA Cell-based Assays Market by Region
  1.4.1 EMEA Cell-based Assays Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Cell-based Assays (2012-2022)
  1.5.1 EMEA Cell-based Assays Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Cell-based Assays Revenue and Growth Rate (2012-2022)

2 EMEA CELL-BASED ASSAYS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Cell-based Assays Market Competition by Players/Manufacturers
  2.1.1 EMEA Cell-based Assays Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Cell-based Assays Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Cell-based Assays Sale Price by Players (2012-2017)
2.2 EMEA Cell-based Assays (Volume and Value) by Type/Product Category
  2.2.1 EMEA Cell-based Assays Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Cell-based Assays Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Cell-based Assays Sale Price by Type (2012-2017)
2.3 EMEA Cell-based Assays (Volume) by Application
2.4 EMEA Cell-based Assays (Volume and Value) by Region
  2.4.1 EMEA Cell-based Assays Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Cell-based Assays Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Cell-based Assays Sales Price by Region (2012-2017)

3 EUROPE CELL-BASED ASSAYS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Cell-based Assays Sales and Value (2012-2017)
  3.1.1 Europe Cell-based Assays Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Cell-based Assays Revenue and Growth Rate (2012-2017)
3.2 Europe Cell-based Assays Sales and Market Share by Type
3.3 Europe Cell-based Assays Sales and Market Share by Application
3.4 Europe Cell-based Assays Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Cell-based Assays Sales Volume by Countries (2012-2017)
  3.4.2 Europe Cell-based Assays Revenue by Countries (2012-2017)
  3.4.3 Germany Cell-based Assays Sales and Growth Rate (2012-2017)
  3.4.4 France Cell-based Assays Sales and Growth Rate (2012-2017)
  3.4.5 UK Cell-based Assays Sales and Growth Rate (2012-2017)
  3.4.6 Russia Cell-based Assays Sales and Growth Rate (2012-2017)
  3.4.7 Italy Cell-based Assays Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Cell-based Assays Sales and Growth Rate (2012-2017)

4 MIDDLE EAST CELL-BASED ASSAYS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Cell-based Assays Sales and Value (2012-2017)
  4.1.1 Middle East Cell-based Assays Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Cell-based Assays Revenue and Growth Rate (2012-2017)
4.2 Middle East Cell-based Assays Sales and Market Share by Type
4.3 Middle East Cell-based Assays Sales and Market Share by Application
4.4 Middle East Cell-based Assays Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Cell-based Assays Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Cell-based Assays Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Cell-based Assays Sales and Growth Rate (2012-2017)
  4.4.4 Israel Cell-based Assays Sales and Growth Rate (2012-2017)
  4.4.5 UAE Cell-based Assays Sales and Growth Rate (2012-2017)
  4.4.6 Iran Cell-based Assays Sales and Growth Rate (2012-2017)

5 AFRICA CELL-BASED ASSAYS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Cell-based Assays Sales and Value (2012-2017)
  5.1.1 Africa Cell-based Assays Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Cell-based Assays Revenue and Growth Rate (2012-2017)
5.2 Africa Cell-based Assays Sales and Market Share by Type
5.3 Africa Cell-based Assays Sales and Market Share by Application
5.4 Africa Cell-based Assays Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Cell-based Assays Sales Volume by Countries (2012-2017)
  5.4.2 Africa Cell-based Assays Revenue by Countries (2012-2017)
  5.4.3 South Africa Cell-based Assays Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Cell-based Assays Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Cell-based Assays Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Cell-based Assays Sales and Growth Rate (2012-2017)

6 EMEA CELL-BASED ASSAYS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 BD Medical (US)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cell-based Assays Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 BD Medical (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Danaher (US)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Cell-based Assays Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Danaher (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific (US)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Cell-based Assays Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Thermo Fisher Scientific (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 General Healthcare (UK)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Cell-based Assays Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 General Healthcare (UK) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck KGaA (Germany)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Cell-based Assays Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck KGaA (Germany) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Perkinelmer (US)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Cell-based Assays Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Perkinelmer (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Charles River Laboratories (US)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Cell-based Assays Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Charles River Laboratories (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Life Technologies (US)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Cell-based Assays Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Life Technologies (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Lonza Group (Switzerland)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Cell-based Assays Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Lonza Group (Switzerland) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cell Signaling Technology (US)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Cell-based Assays Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Cell Signaling Technology (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Promega (US)
6.12 Cisbio Bioassays (France)
6.13 Discoverx (US)
6.14 Proqinase GmbH (Germany)
6.15 Marine Biological Laboratory (US)
6.16 Biospherix (US)
6.17 Essen Bioscience (US)
6.18 Miltenyi Biotec (Switzerland)
6.19 Bioagilytix Labs (US)
6.20 Cell Biolabs (US)
6.21 Biotek Instruments (US)
6.22 Qgel SA (Switzerland)
6.23 Enzo Life Sciences (Switzerland)
6.24 Aurelia Bioscience (UK)
6.25 Selexis SA (US)

7 CELL-BASED ASSAYS MANUFACTURING COST ANALYSIS

7.1 Cell-based Assays Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cell-based Assays

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cell-based Assays Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cell-based Assays Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA CELL-BASED ASSAYS MARKET FORECAST (2017-2022)

11.1 EMEA Cell-based Assays Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Cell-based Assays Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Cell-based Assays Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Cell-based Assays Price and Trend Forecast (2017-2022)
11.2 EMEA Cell-based Assays Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Cell-based Assays Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Cell-based Assays Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Cell-based Assays Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Cell-based Assays Sales Forecast by Type (2017-2022)
11.7 EMEA Cell-based Assays Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cell-based Assays
Figure EMEA Cell-based Assays Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Cell-based Assays Sales Volume Market Share by Type (Product Category) in 2016
Figure Consumables Product Picture
Figure Instruments Product Picture
Figure Services Product Picture
Figure Software Product Picture
Figure EMEA Cell-based Assays Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Cell-based Assays by Application in 2016
Figure Pharmaceutical & Biotechnology Companies Examples
Table Key Downstream Customer in Pharmaceutical & Biotechnology Companies
Figure Academic & Government Institutions Examples
Table Key Downstream Customer in Academic & Government Institutions
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Cell-based Assays Market Size (Million USD) by Region (2012-2022)
Figure Europe Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cell-based Assays Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Cell-based Assays Revenue (Million USD) Status and Forecast by Countries
Figure Africa Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Cell-based Assays Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Cell-based Assays Sales Volume and Growth Rate (2012-2022)
Figure EMEA Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Cell-based Assays Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Cell-based Assays Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Cell-based Assays Sales Share by Players (2012-2017)
Figure 2016 Cell-based Assays Sales Share by Players
Figure 2017 Cell-based Assays Sales Share by Players
Figure EMEA Cell-based Assays Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Cell-based Assays Revenue (Million USD) by Players (2012-2017)
Table EMEA Cell-based Assays Revenue Share by Players (2012-2017)
Table 2016 EMEA Cell-based Assays Revenue Share by Players
Table 2017 EMEA Cell-based Assays Revenue Share by Players
Table EMEA Cell-based Assays Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Cell-based Assays Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Cell-based Assays Sales Share by Type (2012-2017)
Figure Sales Market Share of Cell-based Assays by Type (2012-2017)
Figure EMEA Cell-based Assays Sales Market Share by Type (2012-2017)
Table EMEA Cell-based Assays Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Cell-based Assays Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cell-based Assays by Type in 2016
Table EMEA Cell-based Assays Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Cell-based Assays Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Cell-based Assays Sales Share by Application (2012-2017)
Figure Sales Market Share of Cell-based Assays by Application (2012-2017)
Figure EMEA Cell-based Assays Sales Market Share by Application in 2016
Table EMEA Cell-based Assays Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Cell-based Assays Sales Share by Region (2012-2017)
Figure Sales Market Share of Cell-based Assays by Region (2012-2017)
Figure EMEA Cell-based Assays Sales Market Share in 2016
Table EMEA Cell-based Assays Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Cell-based Assays Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Cell-based Assays by Region (2012-2017)
Figure EMEA Cell-based Assays Revenue Market Share Regions in 2016
Table EMEA Cell-based Assays Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Cell-based Assays Revenue and Growth Rate (2012-2017)
Table Europe Cell-based Assays Sales (K Units) by Type (2012-2017)
Table Europe Cell-based Assays Market Share by Type (2012-2017)
Figure Europe Cell-based Assays Market Share by Type in 2016
Table Europe Cell-based Assays Sales (K Units) by Application (2012-2017)
Table Europe Cell-based Assays Market Share by Application (2012-2017)
Figure Europe Cell-based Assays Market Share by Application in 2016
Table Europe Cell-based Assays Sales (K Units) by Countries (2012-2017)
Table Europe Cell-based Assays Sales Market Share by Countries (2012-2017)
Figure Europe Cell-based Assays Sales Market Share by Countries (2012-2017)
Figure Europe Cell-based Assays Sales Market Share by Countries in 2016
Table Europe Cell-based Assays Revenue (Million USD) by Countries (2012-2017)
Table Europe Cell-based Assays Revenue Market Share by Countries (2012-2017)
Figure Europe Cell-based Assays Revenue Market Share by Countries (2012-2017)
Figure Europe Cell-based Assays Revenue Market Share by Countries in 2016
Figure Germany Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure France Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure UK Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Cell-based Assays Sales (K Units) by Type (2012-2017)
Table Middle East Cell-based Assays Market Share by Type (2012-2017)
Figure Middle East Cell-based Assays Market Share by Type (2012-2017)
Table Middle East Cell-based Assays Sales (K Units) by Applications (2012-2017)
Table Middle East Cell-based Assays Market Share by Applications (2012-2017)
Figure Middle East Cell-based Assays Sales Market Share by Application in 2016
Table Middle East Cell-based Assays Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Cell-based Assays Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Cell-based Assays Sales Volume Market Share by Countries in 2016
Table Middle East Cell-based Assays Revenue (Million USD) by Countries (2012-2017)
Table Middle East Cell-based Assays Revenue Market Share by Countries (2012-2017)
Figure Middle East Cell-based Assays Revenue Market Share by Countries (2012-2017)
Figure Middle East Cell-based Assays Revenue Market Share by Countries in 2016
Figure Saudi Arabia Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Cell-based Assays Sales (K Units) by Type (2012-2017)
Table Africa Cell-based Assays Sales Market Share by Type (2012-2017)
Figure Africa Cell-based Assays Sales Market Share by Type (2012-2017)
Figure Africa Cell-based Assays Sales Market Share by Type in 2016
Table Africa Cell-based Assays Sales (K Units) by Application (2012-2017)
Table Africa Cell-based Assays Sales Market Share by Application (2012-2017)
Figure Africa Cell-based Assays Sales Market Share by Application (2012-2017)
Table Africa Cell-based Assays Sales Volume (K Units) by Countries (2012-2017)
Table Africa Cell-based Assays Sales Market Share by Countries (2012-2017)
Figure Africa Cell-based Assays Sales Market Share by Countries (2012-2017)
Figure Africa Cell-based Assays Sales Market Share by Countries in 2016
Table Africa Cell-based Assays Revenue (Million USD) by Countries (2012-2017)
Table Africa Cell-based Assays Revenue Market Share by Countries (2012-2017)
Figure Africa Cell-based Assays Revenue Market Share by Countries (2012-2017)
Figure Africa Cell-based Assays Revenue Market Share by Countries in 2016
Figure South Africa Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Table BD Medical (US) Cell-based Assays Basic Information List
Table BD Medical (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BD Medical (US) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure BD Medical (US) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure BD Medical (US) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Danaher (US) Cell-based Assays Basic Information List
Table Danaher (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Danaher (US) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Danaher (US) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure Danaher (US) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Thermo Fisher Scientific (US) Cell-based Assays Basic Information List
Table Thermo Fisher Scientific (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific (US) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific (US) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific (US) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table General Healthcare (UK) Cell-based Assays Basic Information List
Table General Healthcare (UK) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure General Healthcare (UK) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure General Healthcare (UK) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure General Healthcare (UK) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Merck KGaA (Germany) Cell-based Assays Basic Information List
Table Merck KGaA (Germany) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA (Germany) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Merck KGaA (Germany) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure Merck KGaA (Germany) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Perkinelmer (US) Cell-based Assays Basic Information List
Table Perkinelmer (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Perkinelmer (US) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Perkinelmer (US) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure Perkinelmer (US) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Charles River Laboratories (US) Cell-based Assays Basic Information List
Table Charles River Laboratories (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Charles River Laboratories (US) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Charles River Laboratories (US) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure Charles River Laboratories (US) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Life Technologies (US) Cell-based Assays Basic Information List
Table Life Technologies (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Life Technologies (US) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Life Technologies (US) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure Life Technologies (US) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Lonza Group (Switzerland) Cell-based Assays Basic Information List
Table Lonza Group (Switzerland) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lonza Group (Switzerland) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Lonza Group (Switzerland) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure Lonza Group (Switzerland) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Cell Signaling Technology (US) Cell-based Assays Basic Information List
Table Cell Signaling Technology (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cell Signaling Technology (US) Cell-based Assays Sales (K Units) and Growth Rate (2012-2017)
Figure Cell Signaling Technology (US) Cell-based Assays Sales Market Share in EMEA (2012-2017)
Figure Cell Signaling Technology (US) Cell-based Assays Revenue Market Share in EMEA (2012-2017)
Table Promega (US) Cell-based Assays Basic Information List
Table Cisbio Bioassays (France) Cell-based Assays Basic Information List
Table Discoverx (US) Cell-based Assays Basic Information List
Table Proqinase GmbH (Germany) Cell-based Assays Basic Information List
Table Marine Biological Laboratory (US) Cell-based Assays Basic Information List
Table Biospherix (US) Cell-based Assays Basic Information List
Table Essen Bioscience (US) Cell-based Assays Basic Information List
Table Miltenyi Biotec (Switzerland) Cell-based Assays Basic Information List
Table Bioagilytix Labs (US) Cell-based Assays Basic Information List
Table Cell Biolabs (US) Cell-based Assays Basic Information List
Table Biotek Instruments (US) Cell-based Assays Basic Information List
Table Qgel SA (Switzerland) Cell-based Assays Basic Information List
Table Enzo Life Sciences (Switzerland) Cell-based Assays Basic Information List
Table Aurelia Bioscience (UK) Cell-based Assays Basic Information List
Table Selexis SA (US) Cell-based Assays Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cell-based Assays
Figure Manufacturing Process Analysis of Cell-based Assays
Figure Cell-based Assays Industrial Chain Analysis
Table Raw Materials Sources of Cell-based Assays Major Manufacturers in 2016
Table Major Buyers of Cell-based Assays
Table Distributors/Traders List
Figure EMEA Cell-based Assays Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Cell-based Assays Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Cell-based Assays Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Cell-based Assays Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Cell-based Assays Sales Market Share Forecast by Region (2017-2022)
Table EMEA Cell-based Assays Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Cell-based Assays Revenue Market Share Forecast by Region (2017-2022)
Table Europe Cell-based Assays Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Cell-based Assays Sales Market Share Forecast by Countries (2017-2022)
Table Europe Cell-based Assays Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Cell-based Assays Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Cell-based Assays Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Cell-based Assays Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Cell-based Assays Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Cell-based Assays Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Cell-based Assays Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Cell-based Assays Sales Market Share Forecast by Countries (2017-2022)
Table Africa Cell-based Assays Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Cell-based Assays Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Cell-based Assays Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Cell-based Assays Sales Market Share Forecast by Type (2017-2022)
Table EMEA Cell-based Assays Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Cell-based Assays Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources